Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase
about
sameAs
MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule networkTumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLySRole of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesisSite-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activationTAK1-dependent signaling requires functional interaction with TAB2/TAB3Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6RANK is essential for osteoclast and lymph node developmentTumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandThe RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKLOsteoimmunology: interactions of the bone and immune systemJun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKLRequirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transductionThe intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesSignaling Pathways in Osteoclast DifferentiationRoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsThe alliance of mesenchymal stem cells, bone, and diabetesReceptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinaseActivation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motifDisabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivoTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingInhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling PathwayMolecules and signaling pathways involved in the expression of OC-STAMP during osteoclastogenesisOsteoclast differentiation and activationRANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitroDeletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone massSingle agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary glandMutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activationGene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling.Development of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesisRANK receptor oligomerisation in the regulation of NFκB signalling.The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase.Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathwaySelective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women.Mechanisms balancing skeletal matrix synthesis and degradation.Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells
P2860
Q22254016-61F452FF-7F92-46B1-AB74-0B3A9A90583FQ24290135-06C91AC4-B78E-437C-8544-62FE5BBD0DF5Q24311417-AC3DBF6E-7C24-41C8-B59A-6692A7CEA000Q24321363-EA948834-6D58-411F-9953-2EC93F9E8DE3Q24324222-8202CF04-2A64-4686-BB13-039AF5F6D794Q24537518-E9D81095-4745-447F-8D28-150E26E4C893Q24598872-DECEA171-20F2-4453-8C59-493688AEFE98Q24653311-591EFC71-9D99-4BBE-8617-6BDBCC75787BQ24654977-50357D78-A81C-4F82-8FA2-9458FAAB0902Q24655113-BCF47517-2939-42A2-A799-B44469F6AC1EQ24673624-AEB9C7DD-2A9D-4676-80F3-F6732A2EAEB0Q24676400-7B46B17D-A541-4DA1-9ADA-D26F9542734CQ24683018-F0A8CC68-1D6E-441A-B8CA-873E9E9B3DAAQ26766637-35A20FE4-779B-4CE3-837E-504DF30689F2Q26853280-076945CD-B83B-498C-BFA4-3D4F345DA988Q27012497-51D8F6D5-F5E4-4AE6-AA00-0998CDEB913AQ28137640-33C661D3-9CE7-4115-A351-348965050207Q28138697-2AD0867D-ABF3-4802-AF7D-1554A6B15ABFQ28191731-338A2BC2-3B63-4CC0-9B76-8A3FA493BF35Q28513445-0B247853-14CC-4AF4-A0B3-407E9DD60523Q28550685-AC3CF5E6-1549-4AE1-BFCB-873BFBDA8DC9Q28592329-C0B876CE-FB63-46DB-BFD2-88C761C4C990Q29547556-F2B76422-FBC6-4B9B-BC99-DE55C2A6A845Q30419245-360D6F4D-EF01-4461-BDCA-2A2973C5B84EQ30534461-36C3A38E-AF4D-492E-BB00-E91D0BBF3317Q33375800-296F882D-734F-48F8-89C7-2E1B2DAC8C52Q33610623-CF1C56C0-FD20-4EBF-81DA-F05E87D15E6CQ33642546-71BE87B9-B7B4-4DE6-B516-E7A6BA532718Q33713375-75900C51-4EA5-4B44-9FC0-CB684F60B8E6Q33738074-9E5D98E3-B7B7-4BBE-ACBF-68838916B47BQ33782305-0B04640F-6982-45BA-8FF2-07C55265AB68Q33793981-778313ED-CF69-47DB-8634-099E63F45F9AQ33825207-F835FA60-7F31-4038-9CEF-C7C64B8A0749Q33846556-F0FB2F56-D129-4D4C-AC36-942FFE3F9909Q33862058-D32ACABA-A0EF-4079-99DA-612FF22BCE15Q34090842-642F0380-1712-45CF-A98F-CFA4109E6C57Q34124144-D0183121-574D-4BBA-9523-631A69B642C5Q34126306-950EA0D3-430B-49C7-8E2C-A916571FACD2Q34129759-C2BC9083-ACBF-4349-80A3-1001CAB48C12Q34162807-D39F1A0C-C1ED-4CCD-ABB2-CE841BF30F83
P2860
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@ast
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@en
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@nl
type
label
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@ast
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@en
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@nl
altLabel
Characterization of the Intrac ...... B AND c-JUN N-TERMINAL KINASE
@ast
Characterization of the Intrac ...... B AND c-JUN N-TERMINAL KINASE
@en
prefLabel
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@ast
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@en
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@nl
P2093
P2860
P3181
P356
P1476
Characterization of the Intrac ...... B AND c-JUN N-TERMINAL KINASE
@en
Characterization of the intrac ...... ab and c-Jun N-terminal kinase
@en
P2093
B B Aggarwal
B G Darnay
B. B. Aggarwal
B. G. Darnay
P. A. Moore
V. Haridas
P2860
P304
P3181
P356
10.1074/JBC.273.32.20551
P407
P577
1998-08-07T00:00:00Z